University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy have developed ...

A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing ...

Genprex’s (GNPX) research collaborators at a major cancer research center in Houston, Texas have published a new study which used the company’s ...

The research uncovers key genetic mutations that affect cancer treatment responses and develops a predictive tool for ...

including lung cancer. The combination craze In fact, the immunotherapy field has seen some of the most frenzied licensing and partnering of any therapy area in 2014. The message this year has ...

A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...

University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also ...

Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.

Company Poised to Enter Booming Bispecific Antibody Market Amid Growing Pharma Interest Providence, RI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ: OCEA) today announced newly ...

A study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence ...

Only some lung cancer patients benefit, especially those with PD-L1 protein on their cells, as it responds well to immunotherapy. Clinical trials are exploring new targets beyond PD-L1, potentially ...